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Aicardi–Goutie`res syndrome
Yoong Wearn Lim1, Lionel A Sanz1, Xiaoqin Xu1, Stella R Hartono1,
Fre´de´ric Che´din1,2*
1Department of Molecular and Cellular Biology, University of California, Davis,
Davis, United States; 2Genome Center, University of California, Davis, Davis,
United States
Abstract Aicardi–Goutie`res syndrome (AGS) is a severe childhood inflammatory disorder that
shows clinical and genetic overlap with systemic lupus erythematosus (SLE). AGS is thought to arise from
the accumulation of incompletely metabolized endogenous nucleic acid species owing to mutations in
nucleic acid-degrading enzymes TREX1 (AGS1), RNase H2 (AGS2, 3 and 4), and SAMHD1 (AGS5).
However, the identity and source of such immunogenic nucleic acid species remain undefined.
Using genome-wide approaches, we show that fibroblasts from AGS patients with AGS1-5
mutations are burdened by excessive loads of RNA:DNA hybrids. Using MethylC-seq, we show that
AGS fibroblasts display pronounced and global loss of DNA methylation and demonstrate that
AGS-specific RNA:DNA hybrids often occur within DNA hypomethylated regions. Altogether, our
data suggest that RNA:DNA hybrids may represent a common immunogenic form of nucleic acids
in AGS and provide the first evidence of epigenetic perturbations in AGS, furthering the links
between AGS and SLE.
DOI: 10.7554/eLife.08007.001
Introduction
Aicardi–Goutie`res syndrome (AGS) is a severe inflammatory encephalopathy characterized by
neurological dysfunction, psychomotor retardation, seizures, unexplained fevers, joint stiffness,
basal ganglia calcification, and chilblain skin lesions (Rice et al., 2007b). Despite its rarity, AGS has
captured the attention of the scientific community due to its clinical, molecular, and genetic
overlap with another, common, systemic autoimmune disorder, systemic lupus erythematosus
(SLE) (Rice et al., 2007a, 2007b; Ravenscroft et al., 2011) (Gunther et al., 2015). Both diseases
are characterized, and to a large extent driven, by excessive expression of interferon alpha, a
potent anti-viral cytokine associated with heightened innate immune response and inflammation
(Crow, 2011). AGS is a monogenic disorder caused by mutations in any one of the six AGS genes.
The AGS genes encode for the 3′ to 5′ single-stranded DNA exonuclease TREX1 (AGS1) (Crow et al.,
2006a), the RNA:DNA hybrid-specific ribonuclease H2 subunits (RNase H2A, B and C, corresponding to
AGS4, 2 and 3, respectively) (Crow et al., 2006b), the 3′ to 5′ exonuclease and dNTP hydrolase
SAMHD1 (AGS5) (Rice et al., 2009; Goldstone et al., 2011), and the RNA adenosine deaminase
ADAR1 (AGS6) (Rice et al., 2012). Recently, gain-of-function mutations in the cytosolic double-stranded
RNA receptor gene IFIH1 have also been shown to be associated with AGS (Rice et al., 2014).
Interestingly, mutations in TREX1 and the RNASEH2 genes have also been implicated in SLE, further
illustrating the genetic link between AGS and SLE (Lee-Kirsch et al., 2007; Gunther et al., 2015). Given
the role of AGS enzymes in DNA and RNA metabolism, the innate immune response in AGS is thought
to be triggered by the accumulation of incompletely metabolized endogenous nucleic acid elements
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(Crow and Rehwinkel, 2009). However, the identity and source of such immunogenic nucleic acid
elements remain undefined.
While genetically well defined, the potential contribution of epigenetic deregulation to
AGS has not been addressed. Characterizing putative epigenetic deregulation in AGS is all the
more justified given that DNA hypomethylation, either spontaneous or caused by drug
exposure, triggers increased B cell autoreactivity and the development of drug-induced and
idiopathic human lupus (Richardson, 1986; Quddus et al., 1993; Yung et al., 1995; Jeffries
et al., 2011; Absher et al., 2013; Zhang et al., 2013). Furthermore, loss of DNA methylation,
albeit modest and restricted to specific autoimmunity-related genes, was reported in SLE
patients (Richardson et al., 1990; Ballestar et al., 2006; Javierre et al., 2010; Jeffries et al.,
2011; Absher et al., 2013), raising the question of whether the same epigenetic deregulation is
shared in AGS.
To uncover the mechanism driving inflammatory responses in AGS, we sought to identify
transcriptional, genetic, and epigenetic perturbations shared among AGS subtypes. For this, we
extensively profiled a series of primary fibroblast cells from AGS patients with mutations in AGS1,
AGS2, and AGS4 and AGS5 using high-throughput sequencing technologies. Transcriptional
profiling via RNA-seq showed that AGS fibroblasts are characterized by an activated antiviral,
immune response with a characteristic interferon signature. Genome-wide profiling of RNA:DNA
hybrid formation revealed that AGS cells accumulate excessive loads of RNA:DNA hybrids.
Whole-genome DNA methylation profiling further indicated that AGS genomes experience global
loss of DNA methylation. Our data therefore provide the first evidence that TREX1, RNASEH2,
and SAMHD1 mutations share common molecular abnormalities including genome-wide DNA
hypomethylation and accumulation of RNA:DNA hybrid species.
eLife digest The immune system protects the body from attack by bacteria, viruses, and other
microbes. A key feature of this system is the ability to discriminate between the body’s own cells and
potential foreign invaders. Occasionally, this process can go wrong and the immune system starts
attacking its own tissues, which can lead to arthritis, diabetes, lupus, and other ‘autoimmune’
diseases.
Aicardi–Goutie`res syndrome (AGS) is an autoimmune disease that leads to severe mental and
physical symptoms. Recent research has revealed that the disease is caused by mutations in genes
that make enzymes called nucleases. In healthy people, these enzymes destroy DNA molecules and
other nucleic acids. In AGS patients, the failure of the nucleases to act is thought to lead to the
accumulation of unwanted DNA and RNA molecules. These molecules, in turn, are thought to be
mistakenly identified by the immune system as ‘foreign’ and to cause an autoimmune response.
However, it is not clear how this works.
Here, Lim et al. studied skin cells called fibroblasts from patients with Aicardi–Goutie`res
syndrome. The experiments found that the patients’ cells had excessive numbers of RNA
molecules binding to sections of matching DNA. These unusual DNA–RNA ‘hybrids’
accumulated in regions of the genome that do not contain many genes, perhaps as a result of
breaks in the DNA. It is possible that they may mimic nucleic acids from viruses and could
trigger an autoimmune response.
In healthy individuals, small ‘methyl’ groups are often attached to DNA in a process known as
DNA methylation. This serves to maintain the stability of the genome and controls the activity of
genes. Unexpectedly, Lim et al. found that the DNA in AGS patients had far fewer methyl groups,
especially in areas where the DNA–RNA hybrids had accumulated. This may lead to genome
destabilization, alterations in gene activity, and may mean that the DNA in these regions may be
mistaken for foreign DNA by the immune system.
Altogether, Lim et al.’s findings suggest that Aicardi–Goutie`res syndrome may be caused by
immune responses triggered by the accumulation of RNA–DNA hybrids and lower levels of DNA
methylation. These findings may aid the development of new therapies to treat Aicardi–Goutie`res
syndrome, lupus, and other similar diseases.
DOI: 10.7554/eLife.08007.002
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Results
Primary AGS fibroblasts show heightened immunomodulatory
transcriptional responses
We first performed RNA-seq to ascertain transcriptional signatures of AGS using primary fibroblasts
from four patients with mutations in AGS1, AGS2, AGS4, or AGS5, and an age-matched healthy
control (see Supplementary file for detailed genotype information). We identified a total of 98 and
209 genes that were significantly up- and down-regulated, respectively, in at least one AGS sample
(Figure 1A; Figure 1—figure supplement 1A; Supplementary file 2). AGS down-regulated genes
significantly associated with ontologies linked to cell adhesion and the extracellular matrix
(Supplementary file 2). These ontologies may be relevant to the skin lesions often observed in AGS and
SLE patients (Rice et al., 2007b). Genes involved in inflammation, immune responses, chemokine
signaling pathways, and sensing of viral nucleic acids were up-regulated in AGS patient cells. Genes
for the major pro-inflammatory cytokine IL1β (Zhao et al., 2013b) and the CXCL5 and CXCL6
chemokines were up-regulated in several AGS patients (Figure 1A,B). Additional immune signaling
genes (IL-33, CXCL3, CXCL1, IL-8, CCL11) were significantly up-regulated in at least one AGS
sample (Supplementary file 2) and gene ontology analysis of AGS deregulated genes identified
cytokine and chemokine signaling pathways as one of weakly enriched terms (Figure 1—figure
supplement 1B). These observations are indicative of a heightened immunomodulatory and
chemotactic response previously identified in multiple autoimmune conditions, including SLE (Tuller
et al., 2013). Genes involved in anti-viral responses (RSAD2, OASL, IGF2BP1, BST2), in particular
interferon-inducible genes, were also up-regulated in multiple AGS samples (Figure 1A,B).
Additional interferon-inducible genes (IFI6, IF44L, ISG15) described previously as representing an
interferon signature in SLE (Baechler et al., 2003) and AGS (Rice et al., 2013) showed up-regulation
in at least one AGS sample (Supplementary file 2). AGS fibroblasts thus exhibit an activated
immune, inflammatory, and anti-viral state, underscoring the systemic nature of the disease and
indicating that fibroblasts are an appropriate cell type to study AGS.
Accumulation of ribonucleotides in genomic DNA is unique to
RNASEH2-deficient AGS patients
While it is likely that dysfunction in AGS enzymes results in an accumulation of incompletely metabolized
immunogenic nucleic acid species (Crow and Rehwinkel, 2009), the identity and source of these
molecules remain unclear. RNase H2 generally degrades RNA:DNA hybrids (Cerritelli and Crouch,
2009) and is specifically responsible for removing single ribonucleotides that are misincorporated
during DNA replication (Reijns et al., 2012). We therefore determined whether ribonucleotide
accumulation is a common feature of AGS. For this, we treated genomic DNA from AGS and control
primary fibroblasts with purified human RNase H2 and measured the presence of resulting nicks by DNA
polymerase I-dependent nick translation in the presence of [α-32P] dCTP. Genomic DNA from wild-type
and RNase H2A-deficient (rnh201Δ) yeast cells that readily incorporate ribonucleotides (Nick McElhinny
et al., 2010) was used as a control. Relative to wild-type, rnh201Δ yeast cells showed a fourfold to
fivefold increase in ribonucleotide accumulation (Figure 2A,B), consistent with prior results
(Nick McElhinny et al., 2010). Cells from two patients mutated in RNASEH2B (AGS2) showed a
twofold to threefold increase in labeling (Figure 2A,C). Cells from two patients mutated in the
catalytic RNase H2A subunit (AGS4) showed a pronounced 10–25-fold increase in ribonucleotides
(Figure 2A,C). Thus, as observed in yeast (Nick McElhinny et al., 2010) and mouse (Reijns et al.,
2012) models, a reduction of human RNase H2 activity leads to elevated levels of ribonucleotides in
genomic DNA. By contrast, no significant increase in ribonucleotide loads could be detected in
patients mutated in TREX1 (AGS1) or SAMHD1 (AGS5) (Figure 2A,B). Thus, while aberrant
accumulation of ribonucleotides may contribute to the severity of the disease in RNase H2-defective
AGS patients, it is unlikely to represent a common form of disease-causing nucleic acids in AGS.
RNA:DNA hybrids accumulate in AGS patients
To identify other species of RNA:DNA hybrids that may be accumulating in AGS, we performed
DRIP-seq, a technique originally developed to profile R-loop formation genome-wide (Ginno et al., 2012).
R-loops are long RNA:DNA hybrid structures that form co-transcriptionally upon re-annealing of the RNA
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Figure 1. AGS fibroblasts exhibit activated immune antiviral response. (A) RNA-seq heatmap showing log2
expression level of genes up-regulated in at least two Aicardi–Goutie`res syndrome (AGS) samples. Two biological
replicates are shown for each sample. Immune-related genes are marked with green dots. (B) Gene expression
changes between AGS samples and control were measured for five immune-related genes by real time reverse-
transcription PCR (RT-qPCR). Y-axis represents fold change in gene expression, normalized to GAPDH gene,
relative to the control sample. SDHA is another housekeeping gene used as control. Each value is the average of
at least two technical replicates. Error bars represent SEM.
DOI: 10.7554/eLife.08007.003
The following figure supplement is available for figure 1:
Figure supplement 1. RNA-seq of AGS and control fibroblasts.
DOI: 10.7554/eLife.08007.004
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transcript to the template DNA strand, forcing the non-template strand into a single-stranded state.
R-loops are enriched at the 5′- and 3′-ends of human genes where they play roles in epigenetic
control and transcription regulation (Ginno et al., 2012, 2013). DRIP-seq revealed that AGS and
control fibroblasts share a total of 15,897 DRIP peaks representing approximately 141 megabases of
genomic space (Figure 3A,C, Figure 3—figure supplement 1A,B). Consistent with prior studies,
32% of these peaks mapped to promoters or gene ends, which represents a strong enrichment over
expected genomic distribution and further indicates that gene ends correspond to R-loop formation
hotspots (Ginno et al., 2013). Our high-coverage DRIP-seq data also revealed that 56% of the
R-loop signal mapped onto gene bodies, suggesting that RNA–DNA entanglements during
transcription are prevalent (Figure 3—figure supplement 1C). By contrast, only 15.6% of common
R-loop peaks mapped to intergenic regions, consistent with a predominant genic origin for R-loop
formation (Figure 3—figure supplement 1C). Overall, common DRIP peaks showed strong overlap
with GC skew (Figure 3B), a key sequence determinant that favors co-transcriptional R-loop
formation (Ginno et al., 2013). The observation that AGS samples display R-loop formation over
expected R-loop forming, GC-skewed, regions indicates that canonical R-loop formation is not
significantly altered in AGS patients (Figure 3—figure supplement 1A,B).
Despite the relative agreement between AGS and control R-loop profiles over a broad set of
common peaks, a large excess of DRIP peaks (33,781 in total) was observed specifically in AGS cells
(Figure 3A). These novel peaks of RNA:DNA hybrids were in many cases unique to each patient
sub-type. While a small number of DRIP peaks were also unique to the control sample, AGS-specific DRIP
peaks in each AGS subtype were both threefold to fourfold greater in numbers, and when combined,
occupied a three to four times larger genomic space than control-specific peaks (Figure 3C). On average,
AGS-specific DRIP peaks occupied an additional 23.8 megabases of DNA sequence. This indicates that all
AGS subtypes are burdened by higher loads of RNA:DNA hybrids in their genomes.
Unlike common DRIP peaks, AGS-specific DRIP peaks were threefold to sevenfold less likely to
overlap with GC skew (Figure 3B), suggesting that they may originate according to a non-canonical
mechanism. Additionally, AGS-specific DRIP peaks were depleted at transcription start sites (TSSs)
Figure 2. Incorporation of ribonucleotides in genomic DNA is only observed in RNase H2-deficient AGS fibroblasts.
(A) Genomic DNA was treated with RNase H2 to reveal the presence of ribonucleotides as single-strand nicks. An
untreated control was used to reveal background single-stranded breaks in genomic DNA preparations. The
intensity of labeling after gel electrophoresis was measured. (B, C) Relative ribonucleotide loads are reported as
fold-increase of radiolabel incorporation of RNase H2-treated over untreated sample. At least three independent
replicates were performed and the error bars indicate SEM.
DOI: 10.7554/eLife.08007.005
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and transcription termination sites (TTSs) (Figure 3D), where R-loops are typically observed (Ginno et al.,
2013). In contrast, AGS2- and AGS4-specific peaks were significantly enriched over intergenic portions of
the human genome (Figure 3D,E). AGS1- and AGS5-specific DRIP peaks were instead enriched over gene
body regions (Figure 3D, Figure 3—figure supplement 1D). Interestingly, all AGS-specific DRIP peaks
were significantly enriched in repeat classes corresponding to long interspersed nuclear elements (LINE)
and long terminal repeats (LTR) retrotransposons (Figure 3D,F,G, Figure 3—figure supplement 1D).
Analysis of the overlap of AGS-specific DRIP peaks with human-specific, retrotransposition-competent,
LINE-1 elements failed to reveal any significant trend (data not shown). Therefore, whether the reported
enrichment of AGS-specific DRIP peaks over LINE and LTR repeats carries biological significance or is simply
a reflection of the increased repeat content of intergenic and intronic space remains to be determined.
Altogether, our results indicate that AGS mutations in TREX1, RNASEH2A, RNASEH2B, and SAMHD1 are
associated with the accumulation of RNA:DNA hybrids over repeat-rich intergenic and gene body regions.
AGS patients show pronounced genome-wide DNA hypomethylation
The observation that RNA:DNA hybrids accumulate over intergenic regions is surprising given that
they are normally maintained in a transcriptionally quiescent state owing to the deposition of silencing
Figure 3. AGS fibroblasts accumulate RNA:DNA hybrids. (A) All genomic loci overlapping with a DRIP peak in at
least one sample are stacked vertically; the position of each peak in a stack is constant horizontally across samples.
Each patient subtype or control occupies a vertical bar, as labeled. Each bar corresponds to merged data sets from
two independent samples. Common peaks (i.e., form in control and at least one AGS sample) are represented in
blue. Control-unique DRIP peaks are shown in pink; lack of DRIP signal over a given peak in any sample is shown as
black. AGS-unique peaks are colored orange, yellow, green, and red in AGS1, 2, 4, and 5, respectively. Brackets on
the right side demarcate common and AGS-specific peaks, respectively. (B, C) Graphs showing the % overlap
between DRIP peaks and blocks of GC skew (B); and the total size of DRIP peaks in each category (C). Color codes
are as described for (A). (D) Enrichment or depletion of AGS-unique DRIP peaks over different genomic features
is shown relative to common DRIP peaks. * indicates p < 0.002 and fold change >20% relative to common peaks.
(E–G) Representative examples of AGS-specific DRIP peaks over an intergenic region (E), a truncated long
interspersed nuclear elements (LINE) element (F) and a truncated long terminal repeats (LTR) element (G).
DOI: 10.7554/eLife.08007.006
The following figure supplement is available for figure 3:
Figure supplement 1. Canonical R-loop genomic patterns are not affected in AGS fibroblasts.
DOI: 10.7554/eLife.08007.007
Lim et al. eLife 2015;4:e08007. DOI: 10.7554/eLife.08007 6 of 21
Research article Genes and chromosomes | Genomics and evolutionary biology
epigenetic marks such as DNA methylation (Yoder et al., 1997). To determine if DNA methylation
patterns were altered in AGS, we performed MethylC-seq (Lister et al., 2009) to profile DNA
methylation at low coverage (3.21–7.82 X coverage) across the same set of primary fibroblasts studied
above (Supplementary file 1). All AGS cells displayed significant, global, DNA hypomethylation
(Figure 4A). AGS2 and 4 cells showed profound DNA hypomethylation, with a ∼20% reduction in
Figure 4. Genome-wide DNA hypomethylation in AGS fibroblasts. (A) Circos plot depicting DNA methylation
along human chromosomes. Each tick mark is colored according to the average percent methylation
across a 2 Mb genomic region (see color legend). (B, C) Metaplots of DNA methylation around transcription
start site (TSS) (B) and transcription termination site (TTS) (C). (D) Percent methylation along chromosome 17.
(E, F) Violin plots depicting methylation levels at different genomic (E) and repeat (F) regions. p-values are
relative to control. **p < 1e-9, *p < 0.01.
DOI: 10.7554/eLife.08007.008
The following figure supplement is available for figure 4:
Figure supplement 1. Methylation profiles of AGS and control cells.
DOI: 10.7554/eLife.08007.009
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genomic methylation levels overall. AGS1 and 5 showed a more moderate, but still highly significant,
5–10% reduction in DNA methylation. This reduction affected TSSs and TTSs (Figure 4B,C;
Figure 4—figure supplement 1A) and spread along the lengths of entire chromosomes (Figure 4D),
significantly impacting nearly all genomic compartments, including genic, intergenic, and repeat regions
(Figure 4E). Analysis of repeat classes further revealed that LINE and LTR elements were significantly
hypomethylated in all AGS subtypes (Figure 4F). Pyrosequencing assays targeting human-specific
LINE-1 elements also revealed a small but significant decrease in DNA methylation over 4 CpG sites
carried at the LINE-1 5′-UTR promoter (Figure 4—figure supplement 1B). SINE elements, satellite
repeats, and other repeat types were significantly hypomethylated in AGS2 and 4 but not always in
AGS1 and 5 (Figure 4F). This profound reduction in DNA methylation was not caused by any
detectable deregulation in the expression of genes encoding for the DNA methylation machinery or
of components of a putative DNA de-methylation system (Figure 4—figure supplement 1C).
To further characterize the DNA hypomethylation observed in AGS cells, we employed a
Hidden Markov Model (HMM) to annotate highly and partially methylated domains (HMDs and
PMDs, respectively) (Schroeder et al., 2011). PMDs in control fibroblasts were generally shared by
AGS fibroblasts but not by embryonic stem (ES) cells (Figure 5A; Figure 5—figure supplement 1A),
consistent with the notion that they represent fibroblast-specific PMDs. AGS2 and AGS4 fibroblasts
displayed broader PMDs than the control cells, while the size of PMD regions in AGS1 and AGS5
cells was relatively unchanged (Figure 5A; Figure 5—figure supplement 1A). Analysis of the
chromatin features associated with PMDs showed that common PMDs resided within silenced
genomic regions enriched for Lamin-B1, a component of the nuclear lamina, and the silencing
mark histone H3 Lysine 9 trimethylation (H3K9me3), as described previously (Berman et al., 2012).
Common PMDs were also strongly depleted for the H3K27me3 mark, a modification associated with
facultative heterochromatin and silencing over developmental genes (Figure 5B, Figure 5—figure
supplement 1B). Interestingly, AGS-specific PMDs, while still associated with Lamin-B1 and to some
extent with H3K9me3, were enriched for H3K27me3, particularly over regions corresponding
normally to large H3K27me3 blocks (Figure 5B,C). This suggests that the DNA hypomethylation
observed in AGS is particularly associated with regions of silenced, condensed chromatin.
We next determined if the regions that became hypomethylated also corresponded to
regions that accumulated RNA:DNA hybrids in DRIP-seq analysis. In AGS1 and AGS5 fibroblasts,
which showed only moderate DNA hypomethylation and limited additional PMDs, DRIP peaks,
whether common or AGS-unique, mostly landed in HMD regions (Figure 5D). This is consistent with
AGS1- and AGS5-specific DRIP peaks being enriched over gene body regions (Figure 3D) since
gene body regions are typically highly methylated (Lister et al., 2009). In sharp contrast, nearly half
of the AGS-unique DRIP peaks in AGS2 and AGS4 fibroblasts landed on PMD regions while only
10–15% of common DRIP peaks matched to PMDs in these two samples. Furthermore, two-thirds
of these PMD-contained AGS-unique DRIP peaks matched to AGS-specific PMDs (Figure 5D,E).
Consistent with this, the DNA methylation levels measured over AGS1-, AGS2-, and AGS4- (but not
AGS5) unique DRIP peaks were significantly lower in their own respective samples compared to the
DNA methylation levels of that same regions measured in control (Figure 5F). Thus, our data show
a remarkable agreement between regions that accumulate RNA:DNA hybrids in the AGS2, AGS4,
and to a lesser extent AGS1 subtypes and regions that undergo DNA hypomethylation.
RNASEH2 depletion triggers DNA hypomethylation
To determine if the loss of DNA methylation observed in AGS patient cells could be directly due
to AGS mutations, we focused on RNASEH2A since AGS4 fibroblasts displayed profound DNA
hypomethylation (Figure 4). We employed a lentivirus-mediated CRISPR/Cas method to knockout
exon 6 in RNASEH2A (RNASEH2A KO) in a HeLa cell line harboring a silent green fluorescent
protein (GFP) reporter gene (HeLa-GFP) (Poleshko et al., 2010). As a control, we treated the same cell
line with a CRISPR vector containing a scramble guide sequence (scramble). Effective gene knockout
was validated by PCR genotyping (not shown) and by Western blots (Figure 6A). To further validate the
knockout, we measured the DNA damage response in RNASEH2A KO and scramble cells using an
antibody against gamma H2AX. As expected from previous reports (Reijns et al., 2012; Gunther et al.,
2015), we observed higher levels of gamma H2AX in RNASEH2A KO cells (Figure 6B), indicative of an
activated DNA damage signaling.
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Figure 5. AGS-specific PMDs are enriched over H3K27me3-marked genomic regions. (A) Venn diagram
displaying partially methylated domains (PMDs) in AGS4 and control fibroblasts compared to embryonic stem
(ES) cells. (B) Location analysis of PMDs over regions marked by H3K9me3, Lamin-B1, and H3K27me3, shown
as fold change relative to genome average (represented by the dotted horizontal line). Stars indicate the
p-value of the deviation from the genome average. (C) Genome browser screenshot showing overlap of AGS-
specific PMDs with H3K27me3. (D) Percent DRIP peaks (common or AGS-unique) in highly methylated
domains (HMDs) and PMDs. The pie charts break down AGS2/4 PMDs to common and unique PMDs.
(E) Genome browser screenshot showing overlap between AGS2/4 PMDs with AGS2/4 DRIP-seq peaks.
(F) Percent DNA methylation of AGS-unique DRIP peaks measured in control and AGS fibroblasts (as
indicated at the bottom of the graph). *p < 7.18e-11, ns = not significant.
DOI: 10.7554/eLife.08007.010
Figure 5. continued on next page
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Compared to scramble, RNASEH2A KO cells showed a clear increase in the number and brightness
of GFP-positive cells (Figure 6C). GFP expression in RNASEH2A KO cells was 14-fold higher than in
scramble cells, as measured by Western blot (Figure 6D), demonstrating reactivation of the GFP
reporter gene. To survey DNA methylation levels in RNASEH2A KO and scramble cells, we focused on
two 5′-UTR portions common to LINE-1 elements and performed DNA methylation sequencing after
sodium bisulfite treatment. RNASEH2A KO cells showed significant DNA hypomethylation relative to
scramble (Figure 6E,F). This suggests a direct effect of RNASEH2A deficiency in triggering DNA
hypomethylation and gene reactivation at least for the loci studied here.
Discussion
One of the key observations from this study is that primary fibroblasts from all four AGS subtypes
studied here experienced global loss of DNA methylation. While additional samples encompassing
other AGS mutations subtypes will need to be studied to confirm this trend, this observation nonetheless
reinforces the similarities between AGS and SLE, although the DNA hypomethylation reported here is
stronger than that previously reported in SLE. In AGS, DNA hypomethylation was found to affect every
genomic compartment, including genic and intergenic regions, unique and repeated sequences
(Figure 4). In AGS2 and AGS4, where the effect was most marked, the DNA hypomethylation led to
the formation of AGS-specific PMDs in addition to those normally observed in fibroblasts (Lister
et al., 2009). Similar to previously characterized PMDs in somatic tissues and cancer samples,
common fibroblasts PMDs described here overlapped with inactive, late-replicating, heterochro-
matic regions associated with H3K9me3 and Lamin-B1 (Hawkins et al., 2010; Berman et al., 2012).
Interestingly, AGS-specific PMDs, but not common PMDs, were also enriched over regions marked
by H3K27me3, a mark of facultative heterochromatin associated with developmental silencing
(Figure 5). This suggests that silent, condensed genomic regions, may in fact be intrinsically prone
to becoming PMDs, and that this tendency is made worse by AGS2 and AGS4 mutations. Our data
further indicate that RNase H2 defects directly drive these epigenetic perturbations given that we
could recapitulate DNA hypomethylation at a subset of LINE-1 sequences and trigger the
reactivation of a silent GFP reporter by knocking out RNASEH2A (Figure 6). While the precise
mechanism responsible for DNA hypomethylation in AGS remains to be elucidated, it is worth
noting that defects in TREX1, RNase H2, and SAMHD1 all trigger the DNA damage response and
are associated with increased genomic instability (Yang et al., 2007; Reijns et al., 2012; Clifford
et al., 2014; Kretschmer et al., 2015). RNase H2 in fact associates with the DNA replication fork
through the PCNA (proliferating cell nuclear antigen) clamp (Bubeck et al., 2011) and TREX1 was
found to translocate to the nucleus upon replication stress where it might be involved in processing
aberrant DNA replication intermediates (Yang et al., 2007). It is therefore possible that the
replication stress caused by AGS mutations indirectly results in defects in replication-coupled,
DNMT1-mediated DNA methylation maintenance (Figure 7) (Law and Jacobsen, 2010). In support
of this notion, a recent report shows that the PCNA clamp unloads from the lagging strand of stalled
DNA replication forks (Yu et al., 2014). Given that the DNMT1 maintenance DNA methyltransferase
binds to PCNA (Leonhardt et al., 1992) and requires PCNA binding for efficient activity
(Schermelleh et al., 2007), it is plausible that replication stress may lead to inefficient DNA
methylation maintenance, particularly in silent, compact regions of the genome such as
heterochromatic regions. An analogous mechanism was proposed to account for how defective
DNA replication may trigger epigenetic instability by uncoupling DNA synthesis from histone
recycling (Sarkies et al., 2010). Interestingly, 5-aza-2′-deoxycytidine, a drug best known as
a DNA-demethylating agent, in fact causes genome-wide DNA damage (Karpf et al., 1999; Palii
et al., 2008; Orta et al., 2013). Finally, pronounced DNA hypomethylation is also known to cause
genomic instability (Jackson-Grusby et al., 2001; Chen et al., 2007; Liao et al., 2015) suggesting
a possible positive feedback loop that may link and amplify defects in either pathways (Figure 7).
Figure 5. Continued
The following figure supplement is available for figure 5:
Figure supplement 1. HMDs and PMDs in AGS fibroblasts.
DOI: 10.7554/eLife.08007.011
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Figure 6. CRISPR/Cas-mediated RNASEH2A knockout induces DNA hypomethylation. (A) Western blot using an anti-
RNase H2A antibody shows successful gene knockout in HeLa-GFP cells. Scramble cells were generated with a CRISPR
vector carrying a scrambled guide RNA sequence. Tubulin was used as a loading control. (B) Immunocytochemistry
confirms elevated DNA damage response in RNASEH2A KO cells; DAPI (blue), gamma H2AX antibody (green).
(C) Bright field and green fluorescent protein (GFP) microscopy images of RNASEH2A KO and scramble control cells.
Knockout of the RNASEH2A gene triggers the reactivation of the silent GFP reporter in HeLa-GFP cells. (D) (Top)
Western blot showing GFP expression in HeLa-GFP cells (RNASEH2A KO and scramble); (bottom) bar graph
quantification of Western blot. (E) Bisulfite methylation sequencing for two different LINE-1 loci in RNASEH2A KO and
scramble control cells. Black and white circles represent methylated and unmethylated CpG sites, respectively. Missing
bubbles indicate that a CpG site is absent from the sequence of that particular molecule. The coordinates for each
fragment analyzed are indicated at top. (F) Quantification of percent methylation at each CpG sites surveyed in panel
E. p-value was calculated using a paired Wilcoxon test with the alternative hypothesis that RNASEH2A KO is less
methylated than scramble.
DOI: 10.7554/eLife.08007.012
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It will be interesting to further investigate the connections between DNA replication stress, DNA
hypomethylation, and epigenetic instability in the context of AGS or of other diseases associated
with epigenetic aberrations such as cancers.
Understanding if and how DNA hypomethylation contributes to autoimmunity in AGS and SLE
is more than ever a priority. One possibility is that DNA hypomethylation results in altered gene
expression profiles. However, our RNA-seq characterization only identified a modest number of
up- and down-regulated genes that were enriched for ontologies reflecting the biology of the
disease itself, such as immunomodulatory genes (Figure 1). There is therefore no evidence for a
global alteration of transcriptional profiles as a result of the DNA hypomethylation in AGS. This
is consistent with the general absence of direct connections between DNA hypomethylation and
gene reactivation (Bestor et al., 2015), including in extremely hypomethylated mouse ES cells
(Li et al., 1992; Tsumura et al., 2006). It remains possible, however, that DNA hypomethylation
may enable the transcription of normally silent and methylated retrotransposable elements. DNA
methylation is indeed the primary silencing force ensuring retrotransposon control in somatic cells
(Walsh et al., 1998; Yoder and Bestor, 1998). If correct, this could lead to the reactivation of
endogenous retroviral-like particles, which if detected by innate immune sensors, could in turn
induce the anti-viral IFNα cytokine, a hallmark of AGS and SLE (Volkman and Stetson, 2014).
Here, we showed that the DNA hypomethylation observed in AGS samples affected LTR, LINE,
Figure 7. Overall model by which AGS1-5 mutations may lead to DNA hypomethylation, RNA:DNA hybrid
accumulation, and IFN-stimulated immune response. See ‘Discussion’ for details.
DOI: 10.7554/eLife.08007.013
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and to a lower extent, SINE repeated DNA elements (Figure 4). However, methylation pyrosequencing
focused on human-specific LINE-1s showed that the extent of DNA hypomethylation at these elements,
while significant, was minimal and that they in fact remained mostly methylated (Figure 4—figure
supplement 1B). Likewise mining of our RNA-seq data sets or targeted real-time reverse-transcription
PCR (RT-qPCR) assays aimed at the LINE-1 mRNA transcript failed to provide convincing evidence
for LINE-1 transcriptional reactivation (data not shown). Finally, Western blots aimed at detecting
the LINE-1 Orf1p protein were negative for AGS fibroblasts even though the protein was easily
detected in Ntera2 control cells (data not shown). Altogether, while we can’t rule out that LINE-1, or
other retroelements, undergo reactivation in AGS cells, particularly in other cell types or at earlier
time points during development, the evidence suggests that the DNA hypomethylation observed in
AGS primary fibroblasts is not accompanied by LINE-1 reactivation.
The second major observation from this study is that all AGS subtypes tested here exhibit large
accumulation of RNA:DNA hybrid species (Figure 3). RNA:DNA hybrids therefore represent
candidate immunogenic nucleic acids in AGS. In contrast, ribonucleotide incorporation in genomic
DNA was only observed in RNase H2-mutated samples (Figure 2). Our DRIP-seq profiling reveals
that AGS2- and AGS4-specific RNA:DNA hybrids map to the intergenic space, away from traditional
R-loop hotspots including genes, promoters, and terminators. AGS1- and AGS5-specific RNA:DNA
hybrids were by contrast enriched over gene body regions (Figure 3D). All AGS-unique RNA:DNA
hybrid peaks showed a lower overlap with GC skew, an important sequence determinant of R-loop
formation (Figure 3B), suggesting that these hybrids may occur by a mechanism distinct from the
well-accepted ‘thread back’ R-loop mechanism (Aguilera and Garcia-Muse, 2012). AGS-specific
DRIP peaks were enriched in LINE-1 and LTR-containing sequences. This enrichment is intriguing in
light of the proposed roles of SAMHD1, RNase H2, and TREX1 in the control of retroelement
transposition (Stetson et al., 2008; Zhao et al., 2013a; Volkman and Stetson, 2014), although,
as discussed above, we did not find convincing evidence for transposon reactivation here.
Alternatively, it is possible that enrichment of AGS-specific RNA:DNA hybrids over LINE-1-rich
regions simply reflects the fact that they map preferentially to intergenic and intronic regions. One
possible clue as to the origin of AGS-specific DRIP peaks stems from the fact that a large fraction of
such peaks in AGS2 and AGS4 samples overlap with AGS-specific PMDs in these two subtypes
(Figure 5). Direct measurements in fact show that AGS-specific DRIP peaks are significantly
hypomethylated in AGS1, AGS2, and AGS4 (Figure 5). Thus, the two main features observed in AGS
samples, excessive RNA:DNA hybrid formation and DNA hypomethylation, often overlap, strongly
supporting a link between both changes in cis. One possible explanation for this overlap is that
regions experiencing DNA hypomethylation as a result of AGS mutations may undergo spurious
transcription that lead to co-transcriptional R-loop formation (Figure 7). Another non-exclusive possibility
is based on the proposition that PMD regions may result from DNA damage and inefficient maintenance
DNA methylation (see above). It was recently described that RNA transcripts may serve as a template for
the repair of double-strand DNA breaks upon hybridization to DNA via Rad52, a key member of the
homologous recombination pathway. Interestingly, RNase H2 activity was shown to block the formation
of these RNA:DNA hybrids (Keskin et al., 2014). It is therefore possible that some of the DNA breaks
caused by AGS mutations and replication stress are repaired according to a pathway prone to RNA:DNA
hybrid formation (Figure 7). While speculative, this model may also account for the lack of overlap with
GC skew since those hybrids are thought to be mediated by Rad52 and not to arise co-transcriptionally.
Experiments aimed at testing this proposal will be important.
One key unanswered question concerns the manner in which RNA:DNA hybrids trigger an immune
response. The cGAS-STING pathway activates the interferon response upon sensing of not only cytosolic
DNA (Sun et al., 2013), but also RNA:DNA hybrids (Mankan et al., 2014). Interestingly, several
studies reported that multiple dsDNA break repair proteins can sense damaged DNA and induce
a STING-mediated type I IFN response (Zhang et al., 2011; Kondo et al., 2013; Hartlova et al.,
2015), thereby highlighting previously underappreciated links between the DNA damage response
and innate immune signaling. Besides STING, it is worth noting that the endosomal receptor TLR9 has
also been identified as an RNA:DNA hybrid sensor (Rigby et al., 2014) in addition to its canonical role in
sensing unmethylated CpG-rich DNA (Hemmi et al., 2000). It is therefore possible that AGS mutations-
induced DNA hypomethylation also contributes to the increased interferon response in AGS (Figure 7).
Interestingly, treatment of colon adenocarcinoma with 5-aza-2′-deoxycytidine, which causes DNA
damage and DNA demethylation, triggers a prominent interferon response (Karpf et al., 1999).
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Future work will be necessary to dissect the pathways by which unmethylated DNA and RNA:DNA
hybrids may be sensed to trigger the innate immune response characteristic of AGS, and by
extension, SLE patients.
Materials and methods
Detection of incorporated ribonucleotides by nick translation assays
Detection of incorporated ribonucleotides was performed as previously described (Hiller et al., 2012).
Briefly, 200 ng of human primary fibroblasts or yeast genomic DNA (wild-type and RNASEH2-deficient)
was treated with 20 nM of purified recombinant human RNase H2 (Loomis et al., 2014) or water in
RNase H2 reaction buffer (50 mM Tris-HCl pH 8, 60 mM KCl, 10 mM MgCl2, 0.01% BSA (Bovine Serum
Albumin), 0.01% Triton) at 37˚C for 1 hr. 20 μM of unlabeled dATP, dGTP and dTTP, plus 3.7 × 105 Bq
[α-32P]-dCTP (PerkinElmer, Santa Clara, CA) and 5 U of Escherichia coli DNA polymerase I (New England
Biolabs, Inc., Ipswich, MA) were added and the reaction was incubated at 16˚C for 30 min and was run
on a 1% TAE (Tris-acetate-EDTA) agarose gel. Visualization was performed using a Storm
PhosphorImager, and bands were quantified using ImageQuant (GE Healthcare, United Kingdom).
Relative ribonucleotide loads were calculated by dividing the radiolabel incorporation in the RNase H2-
treated sample over the untreated sample. Experiments were performed at least in triplicate.
DRIP-seq
DRIP-seq was performed on primary fibroblasts as previously described (Ginno et al., 2012).
Sequencing reads were trimmed with FastqMcf (Aronesty, 2011) before mapping to the hg19
reference genome using BWA 0.6.1 (Li and Durbin, 2009). Peak calling was first performed by
MACS 1.4.2 (Zhang et al., 2008) using input library as control. DRIP peaks were further assigned
onto restriction fragments using BEDtools (Quinlan and Hall, 2010). For control and each AGS
subtype, DRIP peaks from two independent samples were merged into one sample for downstream
analysis. All overlap analysis was performed using BEDTools (Quinlan and Hall, 2010). GC skew
annotation was according to low stringency SkewR peaks as previously described (Ginno et al.,
2013). The enrichment or depletion of AGS-unique DRIP peaks over different genomic regions was
measured as fold-change of percent base-pair overlap of AGS-unique DRIP peaks relative to
common DRIP peaks. The statistical significance of enrichment or depletion of AGS-unique DRIP
peaks over a specific genomic feature was measured as follows: for each AGS-unique peak, 500
shuffled peaks of equal lengths were extracted from the common peak set and their overlap with
various genomic features was recorded as % length overlap. The significance of the difference
in overlap between observed (AGS unique) and expected (shuffled) was calculated using empirical
p-values according to the Monte Carlo method.
Whole-genome bisulfite sequencing (MethylC-seq)
2 μg of genomic DNA was sheared by sonication down to 100–500 bp in size. Sequencing libraries were
constructed as described before (Schroeder et al., 2011). We then performed bisulfite treatment
using EZ DNA methylation-direct kit (Zymo Research, Irvine, CA) following manufacturer’s
instructions. 50 ng of bisulfite-treated DNA was amplified for 15 cycles using Pfu Cx Turbo Hotstart
DNA polymerase (Agilent Technologies, Santa Clara, CA), and the quality of the library was checked
on a 2100 Agilent Bioanalyzer prior to sequencing on an Illumina HiSeq 2000. Sequencing reads
were trimmed as described in DRIP-seq. Mapping was performed using Bismark 0.7.7 (Krueger and
Andrews, 2011), and percent methylation was called using custom Perl script, combind_strand_-
meth.pl. C to T conversion rate was determined as the ratio of converted C in CHG and CHH context
relative to the total number of CHG and CHH. CpG coverage was calculated as the average number
of reads over CpG sites in the genome. Both C to T conversion rate and CpG coverage are reported
in Supplementary file 1. To ensure good coverage and eliminate PCR bias, CpG sites with coverage
below 4× or more than 99.9th percentile were discarded. Circos plot was generated using Circos
0.62–1 (Krzywinski et al., 2009). TSS and TTS metaplots were generated using custom Perl script,
wig_to_metaplot_lowmem.pl. Methylation levels at different genomic regions were calculated
BEDtools (Quinlan and Hall, 2010). Wilcoxon paired test was performed using R with the alternative
hypothesis that the AGS samples are less methylated than the control. PMDs and HMDs were called
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using StochHMM, a HMM-based software (Lott and Korf, 2014) as previously described (Schroeder
et al., 2013) with modifications: PMDs were trained using random 25-kb regions with 25–55%
methylation and HMDs were trained using random 25-kb regions with 60–100%methylation. H3K27me3
and H3K9me3 data sets were obtained from ENCODE normal human dermal fibroblasts (NHDF-Ad).
The lamin B1 data set was obtained from Gene Expression Omnibus (GSE49341).
Reduced representation bisulfite sequencing
Reduced representation bisulfite sequencing (RRBS) library was prepared according to the Myers lab
protocol (Varley et al., 2013) prior to sequencing on an Illumina HiSeq 2000. Sequencing reads were
trimmed with Trim Galore 0.3.3 (Krueger, 2014) and mapped to hg19 genome using Bismark 0.7.7
(Krueger and Andrews, 2011). TSS metaplot was generated using wig_to_metaplot_lowmem.pl.
RNA-seq
RNA-seq libraries were constructed using the Illumina TruSeq kit prior to sequencing on an Illumina
HiSeq 2000. Raw reads were trimmed as before and mapped to the hg19 genome using TopHat 2.0.5
(Trapnell et al., 2009). Read counts for each gene were calculated using HTSeq. Pearson’s correlation
between each pair of biological replicates was calculated by comparing every gene’s log2 normalized
read count (Supplementary file 4). Differential gene expression was identified using DESeq (Anders
and Huber, 2010) using fold change > 2 and FDR (false discovery rate) < 0.1. Pathway analysis was
performed using DAVID (Huang da et al., 2009).
Data access
DRIP-seq, MethylC-seq, RRBS, and RNA-seq data are available at the Gene Expression Omnibus
(GEO) database, under the accession number GSE57353. Custom Perl scripts are available at
https://github.com/ywlim/Perl.
RT-qPCR
Total RNA was extracted from 80% confluent primary fibroblasts using TRI reagent (Life Technologies,
Grand Island, NY) and Direct-zol RNA miniprep kit (Zymo Research). RNA was reverse transcribed to first
strand cDNA using iScript Reverse Transcription Supermix for RT-qPCR (Bio-Rad, Hercules, CA). cDNA was
cleaned up using DNA clean and concentrator (Zymo Research) and resuspended in 10 μl water. For RT-
qPCR, 5 μl of 1:50 dilution of the cDNA was used per well in a 20 μl reaction, along with 2 μl of 10 μM
primer sets and 10 μl of SsoAdvanced Universal SYBR Green Supermix (Bio-Rad). Reactions were run in
duplicate at least on a CFX96 Touch Real-Time PCR Detection System (Bio-Rad) with the following protocol:
95˚C (2 min), 40 cycles of 95˚C (10 s) and 60˚C (15 s). Quantification was calculated using the CFX Manager
software (Bio-Rad). Primer sequences are listed on Supplementary file 3.
CRISPR/Cas knockout of RNASEH2A
RNASEH2A guide RNA sequence was designed using E-CRISP (http://www.e-crisp.org/) and
the corresponding oligonucleotides (top: CACCGTTGGATACTGATTATGGCTC; bottom:
AAACGAGCCATAATCAGTATCCAAC) and scramble oligonucleotides (top: CACCGGCACTAC
CAGAGCTAACTCA; bottom: AAACTGAGTTAGCTCTGGTAGTGCC) were purchased from Life
Technologies. The oligonucleotides were annealed and ligated into lentiCRISPR v2 (Addgene
plasmid 52961) at the BsmBI restriction site. The resulting lentiCRISPR-RNASEH2A and lentiCRISPR-
scramble plasmids were transformed into DH10B cells and purified using Qiagen Plasmid Midi Kit.
To produce lentivirus carrying the CRISPR plasmids, 5 μg lentiCRISPR-RNASEH2A or lentiCRISPR-
scramble, 4 μg psPAX2, and 1.5 μg of pMD2.G were transfected into HEK293T cells on a 10-cm
plate using Turbofect (Life Technologies) following manufacturer’s protocol. Viral supernatant was
collected 48 hr later, filter sterilized with a 0.45-μm filter (Millipore, Billerica MA), and 1 ml of it was
used to infect HeLa-GFP cells on a 6-well plate. 1 μg/ml puromycin was added 24 hr later. 22 days
later, HeLa-GFP-RNASEH2A KO and HeLa-GFP-scramble cells were imaged using GFP
microscopy. Whole-cell protein was extracted and Western blot was performed using antibodies
against RNase H2A (1:1000, ProSci) or GFP (1:500, UC Davis/NIH NeuroMab Facility, Davis, CA), and
tubulin (1:1000, Sigma–Aldrich, St. Louis, MO). Immunocytochemistry was performed on the same cells
using antibody against γH2AX (1:150, Abcam, United Kingdom).
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LINE-1 bisulfite sequencing
600 ng of genomic DNA was bisulfite converted using EZ DNAmethylation-direct kit (Zymo Research) and
eluted in 30 μl elution buffer. 1 μl of it was then PCR amplified using two sets of LINE-1 primers
(Supplementary file 3) (95˚C for 4 min, 20 cycles of 95˚C, 55˚C and 72˚C for 30 s each, 72˚C for 4 min). PCR
products were gel purified and cloned into pDRIVE cloning vector using Qiagen PCR cloning kit (Qiagen,
Valencia, CA) and the resulting vectors were transformed into DH10B cells. Miniprep was performed using
QIAprep Spin Miniprep Kit (Qiagen) and 16 clones were sequenced for each LINE-1 locus. Percent
methylation at each CG site was the ratio of unconverted (CG) vs the sum of unconverted and converted
(TG) molecules.
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